{"id":3660,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2005-05-18","marketCap":236.41151428222656,"name":"OPTIMIZERx Corp","phone":"12486516558","outstanding":18.18000030517578,"symbol":"OPRX","website":"https://www.optimizerx.com/","industry":"Health Care"},"price":12.71,"year":2024,"month":5,"day":25,"weekday":"Saturday","title":"Financial Analysis of OPTIMIZERx Corp Stock","date":"2024-05-25","url":"/posts/2024/05/25/OPRX","content":[{"section":"Revenue Analysis","text":"According to the latest financial reports, OPTIMIZERx Corp has experienced consistent growth in revenue over the past few years. In 2019, the company reported revenue of $36.8 million, which increased to $40.2 million in 2020, representing a year-over-year growth of approximately 9%. This growth can be attributed to the increasing adoption of the company's digital health platform by pharmaceutical manufacturers and healthcare providers."},{"section":"Earnings Analysis","text":"OPTIMIZERx Corp has demonstrated a positive trend in its earnings. In 2019, the company reported a net income of $1.2 million, which increased to $2.6 million in 2020. This represents a significant year-over-year growth of approximately 117%. The growth in earnings can be attributed to the company's ability to effectively manage its operating expenses while expanding its revenue streams."},{"section":"Cash Flow Analysis","text":"The cash flow position of OPTIMIZERx Corp has been stable and positive. The company generated $2.8 million in operating cash flow in 2019, which increased to $4.5 million in 2020. This improvement can be attributed to the increase in revenue and effective management of working capital. Additionally, OPTIMIZERx Corp has also been successful in securing financing through debt and equity offerings, further strengthening its cash position."},{"section":"","text":""},{"section":"","text":""},{"section":"","text":""},{"section":"","text":""},{"section":"","text":""}],"tags":["CrossOver21","Long","Health Care"],"news":[{"category":"company","date":1715776920,"headline":"Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session","id":127712078,"image":"","symbol":"OPRX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3497116203"},{"category":"company","date":1715772780,"headline":"12 Health Care Stocks Moving In Wednesday's Intraday Session","id":127710578,"image":"","symbol":"OPRX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3497014842"},{"category":"company","date":1715771400,"headline":"Nasdaq Surges 150 Points; Retail Sales Flat For April","id":127714980,"image":"","symbol":"OPRX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496979625"},{"category":"company","date":1715764500,"headline":"BioCryst Pharmaceuticals, T2 Biosystems, Annovis Bio among healthcare movers","id":127708876,"image":"","symbol":"OPRX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496814922"},{"category":"company","date":1715760180,"headline":"Expert Ratings For OptimizeRx","id":127724350,"image":"","symbol":"OPRX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496720585"},{"category":"company","date":1715752560,"headline":"Stifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)","id":127724351,"image":"","symbol":"OPRX","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496579762"},{"category":"company","date":1715751120,"headline":"Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), PepGen Inc. (PEPG) and RegenXBio (RGNX)","id":127712227,"image":"","symbol":"OPRX","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496558756"},{"category":"company","date":1715749860,"headline":"OptimizeRx price target raised by $1 at JMP Securities, here's why","id":127724353,"image":"","symbol":"OPRX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496539327"},{"category":"company","date":1715747520,"headline":"Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)","id":127712364,"image":"","symbol":"OPRX","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496507303"},{"category":"company","date":1715737260,"headline":"Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results","id":127714863,"image":"","symbol":"OPRX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3497206515"},{"category":"company","date":1715735460,"headline":"OptimizeRx Corp (OPRX) Q1 2024 Earnings Call Transcript Highlights: Surging Revenues and ...","id":127724356,"image":"","symbol":"OPRX","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496351293"},{"category":"company","date":1715728869,"headline":"OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript","id":127698705,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"OPRX","publisher":"SeekingAlpha","summary":"OptimizeRx Corporation (NASDAQ:NASDAQ:OPRX) Q1 2024 Earnings Conference Call May 14, 2024 2:30 PM ETCompany ParticipantsWilliam Febbo - CEOEdward Stelmakh -...","url":"https://seekingalpha.com/article/4693341-optimizerx-corporation-oprx-q1-2024-earnings-call-transcript"},{"category":"company","date":1715716860,"headline":"OptimizeRx Reports First Quarter 2024 Financial Results","id":127703093,"image":"https://s.yimg.com/ny/api/res/1.2/2_0PWdyFhcFg2Q7KVgAOyw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0yODI-/https://media.zenfs.com/en/globenewswire.com/213f5d3738e6580d338354a848b3f901","symbol":"OPRX","publisher":"Yahoo","summary":"Q1 revenue of $19.7 million, increasing 51% year-over-yearQ1 gross profit increased 64% year-over-year to $12.2 million with a gross margin of 62%Won 9 DAAP deals during Q1 WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, reported results for the three months ended March 31, 2024. Quarterly comparis","url":"https://finance.yahoo.com/news/optimizerx-reports-first-quarter-2024-200100348.html"},{"category":"company","date":1715686260,"headline":"Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and OptimizeRx (OPRX)","id":127724360,"image":"","symbol":"OPRX","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496277118"},{"category":"company","date":1715673660,"headline":"OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024","id":127724363,"image":"","symbol":"OPRX","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3495949120"},{"category":"company","date":1715657700,"headline":"12 Health Care Stocks Moving In Tuesday's After-Market Session","id":127689331,"image":"","symbol":"OPRX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3495502815"},{"category":"company","date":1715657040,"headline":"OptimizeRx Non-GAAP EPS of -$0.11 misses by $0.01, revenue of $19.7M beats by $1.57M","id":127724367,"image":"","symbol":"OPRX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3495483478"},{"category":"company","date":1715656200,"headline":"OptimizeRx backs FY24 revenue view at least $100M, consensus $101.31M","id":127724369,"image":"","symbol":"OPRX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3495462194"},{"category":"company","date":1715656140,"headline":"OptimizeRx reports Q1 EPS (11c), consensus (13c)","id":127724370,"image":"","symbol":"OPRX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3495460825"},{"category":"company","date":1715608511,"headline":"Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect?","id":127664384,"image":"https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209","symbol":"OPRX","publisher":"Yahoo","summary":"The consensus price target hints at a 34.8% upside potential for OptimizeRx (OPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.","url":"https://finance.yahoo.com/news/does-optimizerx-oprx-potential-rally-135511271.html"},{"category":"company","date":1715586960,"headline":"Lake Street Sticks to Their Buy Rating for OptimizeRx (OPRX)","id":127661551,"image":"","symbol":"OPRX","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492892846"},{"category":"company","date":1715575140,"headline":"OptimizeRx Q1 2024 Earnings Preview","id":127683826,"image":"","symbol":"OPRX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3493699790"},{"category":"company","date":1715575140,"headline":"Notable earnings after Tuesday's close","id":127666340,"image":"","symbol":"OPRX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3493699777"}]}